Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID-19) pandemic: A case series 20/01/2022 12:53 Baraliakos X et.al.; Clin Case Rep. 2022 Jan 20;10(1):e05205. קרא עוד ←
Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with ankylosing spondylitis during the coronavirus disease (COVID-19) pandemic: A case series 10/01/2022 16:14 Vijayan S et.al.; Clin Case Rep. 2022 Jan 13;10(1):e05233 קרא עוד ←